CA933932A - Medicaments with antineoplastic activity - Google Patents

Medicaments with antineoplastic activity

Info

Publication number
CA933932A
CA933932A CA088348A CA88348A CA933932A CA 933932 A CA933932 A CA 933932A CA 088348 A CA088348 A CA 088348A CA 88348 A CA88348 A CA 88348A CA 933932 A CA933932 A CA 933932A
Authority
CA
Canada
Prior art keywords
medicaments
antineoplastic activity
antineoplastic
activity
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA088348A
Other languages
English (en)
Other versions
CA88348S (en
Inventor
Meisels Alexander
Storni Angelo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis Corp
Original Assignee
Ciba Geigy Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CH1091269A external-priority patent/CH511877A/de
Priority claimed from CH1091169A external-priority patent/CH511878A/de
Application filed by Ciba Geigy Corp filed Critical Ciba Geigy Corp
Application granted granted Critical
Publication of CA933932A publication Critical patent/CA933932A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/426—1,3-Thiazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/54—Nitrogen and either oxygen or sulfur atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
CA088348A 1969-07-17 1970-07-16 Medicaments with antineoplastic activity Expired CA933932A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH1091269A CH511877A (de) 1969-07-17 1969-07-17 Verfahren zur Herstellung eines neuen Thiosemicarbazons
CH1091169A CH511878A (de) 1969-07-17 1969-07-17 Verfahren zur Herstellung von neuen Azinen

Publications (1)

Publication Number Publication Date
CA933932A true CA933932A (en) 1973-09-18

Family

ID=25707532

Family Applications (1)

Application Number Title Priority Date Filing Date
CA088348A Expired CA933932A (en) 1969-07-17 1970-07-16 Medicaments with antineoplastic activity

Country Status (9)

Country Link
CA (1) CA933932A (cs)
CS (1) CS153558B2 (cs)
DK (1) DK127430B (cs)
ES (1) ES381892A1 (cs)
FI (1) FI52086B (cs)
NO (1) NO127923B (cs)
PL (1) PL71711B1 (cs)
SE (1) SE362251B (cs)
YU (1) YU33392B (cs)

Also Published As

Publication number Publication date
DK127430B (da) 1973-11-05
NO127923B (cs) 1973-09-03
YU33392B (en) 1976-12-31
FI52086B (cs) 1977-02-28
ES381892A1 (es) 1972-12-01
SE362251B (cs) 1973-12-03
CS153558B2 (cs) 1974-02-25
PL71711B1 (en) 1974-06-29
YU178170A (en) 1976-06-30

Similar Documents

Publication Publication Date Title
CA954522A (en) Amidine derivatives
CA960690A (en) Phenethylamine derivatives
ZA704898B (en) New medicaments with antineoplastic activity
CA948642A (en) Phenazone-paracetamol complex
CA919548A (en) Anaesthetizing unit with vapourizer
CA981952A (en) Forming arrangement
CA933932A (en) Medicaments with antineoplastic activity
AU456028B2 (en) New medicaments with antineoplastic activity
AU1765970A (en) New medicaments with antineoplastic activity
AU1654170A (en) Benzoisothiazol derivatives
CA947254A (en) Nurser
CA911969A (en) Stolport structure
AU424793B2 (en) Improvements relating to medicaments
AU294363B2 (en) Copolyesters
CA956607A (en) Nurser
CA814837A (en) Spar
CA823177A (en) Medicament preparations
AU433869B2 (en) Phenethylamine derivatives
CA827931A (en) Panel-holding structure
CA961043A (en) Diarylmethane derivatives
AU458374B2 (en) Diarylmethane derivatives
CA806509A (en) Mobilfeeder-wheel arrangement
CA814460A (en) Bismuth-chlorhydroxyquinoline complex
CA965630A (en) Ophthalmoscope
AU443225B2 (en) Medicinal substance